Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cyclo Therapeutics Inc
CYTHCurrent price
1.47 USD
-0.07 USD (-4.55%)
Last closed
1.44 USD
Company
www.cyclotherapeutics.com
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
29 371 106 USD
Yield for 12 month
-24.23 %
Week
Month
Year
CYTH
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. Address: 6714 NW 16th Street, Gainesville, FL, United States, 32653
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+1 375 760 USD
Last Year
+1 585 756 USD
Current Quarter
+495 477 USD
Last Quarter
+117 118 USD
Current Year
+1 236 831 USD
Last Year
+1 429 676 USD
Current Quarter
+456 710 USD
Last Quarter
+97 209 USD
Key Figures CYTH
1 year
3 years
5 years
10 years
EBITDA
-19 371 112 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-172.09 %
PEG Ratio
–
Return On Equity TTM
-850.71 %
Wall Street Target Price
5 USD
Revenue TTM
951 809 USD
Book Value
-0.054 USD
Revenue Per Share TTM
0.074 USD
Dividend Share
–
Quarterly Revenue Growth YOY
9.6 %
Dividend Yield
–
Gross Profit TTM
1 225 812 USD
Earnings Share
-1.59 USD
Diluted Eps TTM
-1.59 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CYTH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CYTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
09.12.2020
Dividend Date
09.12.2020
Stock Valuation CYTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.5728
Price Sales TTM
8.6536
Enterprise Value EBITDA
-0.8707
Price Book MRQ
2.8412
Financials CYTH
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators CYTH
For 52 weeks
0.67 USD
2.57 USD
50 Day MA
1.25 USD
Shares Short Prior Month
132 957
200 Day MA
1.31 USD
Short Ratio
3.55
Shares Short
126 405
Short Percent
0.82 %
Google
Apple
Facebook